Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-30T22:59:05.802Z Has data issue: false hasContentIssue false

Levodopa in Senile Dementia

Published online by Cambridge University Press:  29 January 2018

Brian R. Ballinger
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF
Kate Johnson
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF
David S. G. Kay
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF
Christopher Lewis
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF
Allan S. Presly
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF
Anne H. W. Smith
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1979 

References

Johnson, K., Presly, A. S. & Ballinger, B. R. (1978) Levodopa in senile dementia. British Medical Journal, i, 1625.Google Scholar
Lewis, C., Ballinger, B. R. & Presly, A. S. (1978) Trial of levodopa in senile dementia. British Medical Journal, i, 550.Google Scholar
Smith, A. H. W., Kay, D. S. G., Johnson, K. & Ballinger, B. R. (1979) Bromocriptine in senile dementia—a placebo controlled double blind trial. I.R.C.S. Medical Science, 7, 463.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.